Business Context and Reporting Period
This Form 8-K was filed by Inpixon (trading symbol: INPX) on November 6, 2019. The report details a material definitive agreement entered into on the same date between the Company and Iliad Research and Trading, L.P. ("Iliad"), a significant holder of the Company's debt.
Key Financial Metrics and Transaction Details
- Debt Conversion: The Company exchanged a partitioned portion of a promissory note for common stock.
- Note Principal Converted: $157,500.
- Shares Issued: 1,750,000 shares of Common Stock.
- Effective Price Per Share: $0.09.
- Outstanding Debt (Original Note): $1,284,780.39 as of November 6, 2019 (prior to the $157,500 reduction).
- Other Outstanding Debt: Approximately $963,000 owed to Iliad (issued Sept 17, 2019) and approximately $9.8 million owed to Chicago Venture Partners, L.P. (an affiliate of Iliad) as of October 27, 2019.
- Total Outstanding Common Stock: 75,743,378 shares as of November 6, 2019 (inclusive of the new issuance).
Material Changes Versus Prior Period
The primary material change is the reduction of the Company's debt obligations by $157,500 and a corresponding increase in outstanding equity by 1,750,000 shares. This transaction alters the capital structure by converting a portion of senior debt into equity without the Company incurring additional cash costs.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, revenue projections, or management commentary regarding future operations. The transaction was executed under Section 3(a)(9) of the Securities Act of 1933, relying on an exemption from registration because the shares were issued in exchange for an outstanding security with no additional consideration or commissions paid. The shares are subject to public resale once held by Iliad's brokerage firm.
Investor Verification Checklist
- Verify the total aggregate debt exposure to Iliad and its affiliate, Chicago Venture Partners, which exceeds $10.8 million as of late October 2019.
- Confirm the dilution impact of the 1,750,000 new shares on existing shareholders.
- Review the full text of the Exchange Agreement (Exhibit 10.1) for any covenants or conditions not summarized in this report.
- Check the status of the remaining $1,127,280.39 balance on the Original Note and the terms of the other outstanding notes.